EA038580B9 - Steroid derivative fxr agonist - Google Patents

Steroid derivative fxr agonist

Info

Publication number
EA038580B9
EA038580B9 EA201891690A EA201891690A EA038580B9 EA 038580 B9 EA038580 B9 EA 038580B9 EA 201891690 A EA201891690 A EA 201891690A EA 201891690 A EA201891690 A EA 201891690A EA 038580 B9 EA038580 B9 EA 038580B9
Authority
EA
Eurasian Patent Office
Prior art keywords
fxr agonist
steroid derivative
derivative fxr
relates
steroid
Prior art date
Application number
EA201891690A
Other languages
Russian (ru)
Other versions
EA038580B1 (en
EA201891690A1 (en
Inventor
Хайин Хэ
Хуалин Сяо
Пэн ЛИ
Чуньянь Ду
Чжи Ло
Шухуэй Чэнь
Original Assignee
Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. filed Critical Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд.
Priority claimed from PCT/CN2017/072567 external-priority patent/WO2017129125A1/en
Publication of EA201891690A1 publication Critical patent/EA201891690A1/en
Publication of EA038580B1 publication Critical patent/EA038580B1/en
Publication of EA038580B9 publication Critical patent/EA038580B9/en

Links

Abstract

The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, and relates to applications thereof in the preparation of drugs for treating FXR related diseases.
EA201891690A 2016-05-18 2017-01-25 Steroid derivative fxr agonist EA038580B9 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610331759 2016-05-18
PCT/CN2017/072567 WO2017129125A1 (en) 2016-01-28 2017-01-25 Steroid derivative fxr agonist

Publications (3)

Publication Number Publication Date
EA201891690A1 EA201891690A1 (en) 2019-04-30
EA038580B1 EA038580B1 (en) 2021-09-17
EA038580B9 true EA038580B9 (en) 2021-10-05

Family

ID=66436959

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891690A EA038580B9 (en) 2016-05-18 2017-01-25 Steroid derivative fxr agonist

Country Status (1)

Country Link
EA (1) EA038580B9 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60205891T2 (en) * 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. STEROIDS AS AGONISTS FOR FXR
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
WO2016086134A1 (en) * 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) * 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
LT3277286T (en) * 2015-03-31 2021-07-26 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
WO2016173493A1 (en) * 2015-04-28 2016-11-03 Shanghai De Novo Pharmatech Co. Ltd. Sulfonylaminocarbonyl derivative, pharmaceutical composition and uses thereof
JP2018519246A (en) * 2015-04-28 2018-07-19 ジエンス ハンセン ファーマセウティカル グループ カンパニー リミテッド Cholic acid derivative, production method thereof and pharmaceutical use

Also Published As

Publication number Publication date
EA038580B1 (en) 2021-09-17
EA201891690A1 (en) 2019-04-30

Similar Documents

Publication Publication Date Title
PH12018550120A1 (en) Steroid derivative fxr agonist
PH12018501807A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseas
MX2017013797A (en) Janus kinase inhibitor.
MX2015016344A (en) Imidazopyrrolidinone derivatives and their use in the treatment of disease.
PH12018502109A1 (en) Medicine obtained by combining fxr agonist and arb
MX368903B (en) THERAPEUTIC COMPOUNDS and USES THEREOF.
PH12019501955A1 (en) Tri-cycle compound and applications thereof
MX2015016425A (en) Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease.
CY1124251T1 (en) CARBOXAMIDE DERIVATIVES
PH12016502352A1 (en) Pharmaceutical composition
PH12016502353A1 (en) Pharmaceutical composition
MX2016014946A (en) Carboxamide derivatives.
SA520411635B1 (en) Fused Ring Derivative as A2A Receptor Inhibitor
MX2017013099A (en) Methods for the treatment of inflammatory disorders.
PH12017501955A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease
MX2017002544A (en) Isoquinolinone derivatives useful in the treatment of cancer.
EP3659597A3 (en) Compositions and methods for drug sensitization of parasites
MX2017002627A (en) Derivatives of macrocyclic n-aryl-2-amino-4-aryl-pyrimidine polyethers as inhibitors of ftl3 and jak.
EA038580B9 (en) Steroid derivative fxr agonist
MX2017002747A (en) Derivatives of macrocyclic n-aryl-tricyclopyrimidine-2-amine polyethers as inhibitors of ftl3 and jak.
PH12016502247A1 (en) Carboxamide derivatives
EA201891136A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AS A ACTIVE INGREDIENT DERIVATIVE 7-AZAINDOLIN-2-SHE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent